PRESERVAÇÃO DA MASSA MUSCULAR DURANTE O TRATAMENTO FARMACOLÓGICO DA OBESIDADE: O IMPACTO DAS TERAPIAS INCRETÍNICAS SOBRE A COMPOSIÇÃO CORPORAL E O RISCO DE SARCOPENIA
Cíntia Rodrigues de Azevedo, Caio Lima Adário, Gabriel Ferreira Lopes, Letícia Assunção Corrêa, Pedro Henrique De Campos Lico · 2026
Read PRESERVAÇÃO DA MASSA MUSCULAR DURANTE O TRATAMENTO FARMACOLÓGICO DA OBESIDADE: O IMPACTO DAS TERAPIAS INCRETÍNICAS SOBRE A COMPOSIÇÃO CORPORAL E O RISCO DE SARCOPENIA by Cíntia Rodrigues de Azevedo, Caio Lima Adário, Gabriel Ferreira Lopes, Letícia Assunção Corrêa, Pedro Henrique De Campos Lico (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/openalex-w7214365716.txt.
Description
Cíntia Rodrigues de Azevedo led a 2026 integrative review on a side effect of modern obesity drugs: loss of lean mass along with fat. Drugs based on gut hormones, including semaglutide and tirzepatide, produce large weight losses. Part of what is lost can be lean tissue, raising concern about sarcopenia, the weakening of muscle, especially in older or frail patients.
The reviewed studies confirm strong fat loss paired with some lean loss, but the authors stress that lean mass is not the same as muscle, since it also includes water and organs. Resistance training and enough protein can reduce lean tissue loss during treatment. They argue obesity care should track body composition over time, not celebrate scale weight alone while strength quietly declines.
Catalog record
| CREATOR | Cíntia Rodrigues de Azevedo, Caio Lima Adário, Gabriel Ferreira Lopes, Letícia Assunção Corrêa, Pedro Henrique De Campos Lico |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | OpenAlex / Revista Ibero-Americana de Humanidades, Ciências e Educação |